For the sixth year, Gilead Sciences Nordic proudly announces the Gilead Sciences Nordic Fellowship Programme, which will provide funding totaling SEK 3,000,000 to projects within HIV, liver diseases, and hematology/oncology executed in the Nordic countries.
The aim of the Gilead Sciences Nordic Fellowship Programme is to award financial grants to encourage the development, exploration and dissemination of new ideas, generating best practice in the delivery of patient-centred care in three areas – HIV, liver diseases (LVD), and hematology/oncology (ONC). Evidence generated from Fellowship projects provides the opportunity to shape public health policy and practice, or to generate new studies or joint ventures to shape clinical care pathways. The projects supported under the Gilead Sciences Nordic Fellowship Programme are independent of the use of any particular therapeutic agent.
Brochure outlining what the fellowship program entails
Applications are invited from health-care organisations and/or academic institutions.